Changchang Jia

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Journal of clinical and translational hepatology

Oncogenesis

Genes

Journal of cellular physiology

Third Affiliated Hospital of Sun Yat-Sen University

Sun Yat-Sen University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Third Affiliated Hospital of Sun Yat-Sen University Oct 01 2013

China

PHD :: Cell-gene Therapy Translation Medicine Research Center

Education History

Sun Yat-Sen University Sep 01 2007 - Jul 01 2012

China

PHD :: Cell-gene Therapy Translational Medicine Research Center

Publications

Dongbo Qiu, Tiantian Wang, Yi Xiong, Kun Li, Xiusheng Qiu, Yuan Feng, Qinghai Lian, Yunfei Qin, Kunpeng Liu, Qi Zhang, Changchang Jia
TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma. Oncogenesis 13 (1) (2024)
Yongsheng Tang, Zenan Yuan, Xu Lu, Yingqiu Song, Shuguang Zhu, Chunhui Qiu, Qi Zhang, Binsheng Fu, Changchang Jia, Hua Li
RAMP1 Protects Hepatocytes against Ischemia-reperfusion Injury by Inhibiting the ERK/YAP Pathway. Journal of clinical and translational hepatology 12 (4) (2024)
Yongsheng Tang, Zenan Yuan, Xu Lu, Yingqiu Song, Shuguang Zhu, Chunhui Qiu, Qi Zhang, Binsheng Fu, Changchang Jia, Hua Li
RAMP1 Protects Hepatocytes against Ischemia-reperfusion Injury by Inhibiting the ERK/YAP Pathway. Journal of clinical and translational hepatology 12 (4) (2024)
Yongsheng Tang, Zenan Yuan, Xu Lu, Yingqiu Song, Shuguang Zhu, Chunhui Qiu, Qi Zhang, Binsheng Fu, Changchang Jia, Hua Li
RAMP1 Protects Hepatocytes against Ischemia-reperfusion Injury by Inhibiting the ERK/YAP Pathway. Journal of clinical and translational hepatology 12 (4) (2024)
Yinkui Chen, Xiusheng Qiu, Donghao Wu, Xu Lu, Guanghui Li, Yongsheng Tang, Changchang Jia, Zhiyong Xiong, Tiantian Wang
PROZ Associated with Sorafenib Sensitivity May Serve as a Potential Target to Enhance the Efficacy of Combined Immunotherapy for Hepatocellular Carcinoma. Genes 13 (9) (2022)
Changchang Jia, Zhicheng Yao, Zexiao Lin, Liyun Zhao, Xiurong Cai, Shaohong Chen, Meihai Deng, Qi Zhang
circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression. Journal of cellular physiology 236 (2) (2020)

Changchang Jia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Changchang Jia